A Case Report of Bullous Emphysema in an Adolescent: Congenital Malformation or Outcome of Bronchopulmonary Dysplasia?
Pulmonary emphysema belongs to the group of chronic obstructive pulmonary diseases, and in
pediatric pulmonology is one of the complex diagnoses that require a careful differential diagnosis. The
article describes the possible causes of the formation and clinical manifestations of pulmonary
emphysema in children. We present a clinical case of bullous emphysema in a teenager. This case shows
that a detailed examination using such a modern diagnostic method as high-resolution computed
tomography played a crucial role in establishing the patient's correct diagnosis. However, establishing the
nature of this pathological process in the child was very difficult. Perhaps an earlier diagnosis could
prevent severe irreversible changes in a teenager's lungs would avoid developing the diffuse
2. Ribeiroa JD, Fischer GB. Chronic obstructive pulmonary diseases in children. J Pediatr (RioJ). 2015; 91 (6 Supp l1): P. 11-25. doi: https://doi.org/10.1016/j.jped.2015.06.003.
3. Robert A. Stockley. The multiple facets of alpha-1-antitrypsin. Ann Transl Med. 2015 Jun; 3(10): 130. doi: 10.3978/j.issn.2305-5839.2015.04.25.
4. Siddiqui NA, Mansour MK, Nookala V. Bullous Emphysema. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. [last update: July 4, 2020; the date of access 2020 Nov 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537243/
5. Goldberg C, Carey KE. Bullous Lung Disease. West J Emerg Med. 2013 Sep; 14(5): 450–451. doi: 10.5811/westjem.2013.3.16276.
6. Najam AS.; Vinod N. Bullous Emphysema. StatPearls Publishing LLC 2019. PMID: 30725928. Available at https://www.ncbi.nlm.nih.gov/books/NBK537243/
7. Demir OF, Hangu M and Kose M. Congenital lobar emphysema: diagnosis and treatment options. Int J Chron Obstruct Pulmon Dis. 2019; 14: 921–928. doi: 10.2147/COPD.S170581.
8. Bush A, Harcout J, Hewitt RJ, Nicholson AG. Congenital lung disease In: Wilmott RW, Deterding R, Li A, et al., editors. Kendig’s Disorders of the Respiratory Tract in Children. 9th ed. Philadelphia (PA): Elsevier, Inc; 2019:321–322.
9. Seo T, Ando H, Kaneko K, Ono Y, Tainaka T, Sumida W, Hayakawa M, Itakura A. Two cases of prenatally diagnosed congenital lobar emphysema caused by lobar bronchial atresia. J Pediatr Surg. 2006 Nov;41(11): e17-20. doi: 10.1016/j.jpedsurg.2006.08.037.
10. Mukhtar S, Trovela DAV. Congenital Lobar Emphysema. StatPearls [Internet]. (Last Update: August 10, 2020; the date of access 2020 Dec 05]. Available from: https://www.statpearls.com/ArticleLibrary/viewarticle/21038.
11. Balaji MD, Sowmya S, Naveen KS. Congenital lobar emphysema presenting as recurrent pneumonia in an infant. Int J Contemp Pediatr. 2017 Mar;4(2):655-657. doi: http://dx.doi.org/10.18203/2349-3291.ijcp20170726.
12. Badiu I., Hiriscau A., Lupan I., Samasca G. (2017). Congenital Lobar Emphysema in Infants. Maedica (Buchar), vol. 12 (2), pp. 133-135.
13. Santra A., Dutta P., Manjhi R., Pothal S. (2014). Congenital lobar emphysema presenting at late childhood: A rare case report. Lung India, vol. 31(3), pp. 302–304. doi: 10.4103/0970-2113.135792.
14. Ruggeri P, Calcaterra S and Girbino G. Bullous emphysema as first presentation of Ehlers-Danlos syndrome in monozygotic twins. Respir Med Case Rep. 2015; 14: 40–42. doi: 10.1016/j.rmcr.2014.12.002.
15. Karpman C, Aughenbaugh GL, Ryu JH. Pneumothorax and Bullae in Marfan Syndrome. Respiration 2011;82:219–224. doi: 10.1159/000322958.
16. Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2013 Jun; 7(3): 161–173. doi: 10.1177/1753465813479428.
17. Bhandari A, McGrath-Marrow S. Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol; 2013; 37:132–137. doi: 10.1053/j.semperi.2013.01.010.
18. McGrath-Morrow SA, Collaco JM. Bronchopulmonary dysplasia: what are its links to COPD? Ther Adv Respir Dis. 2019 Jan-Dec; 13:1753466619892492. doi: 10.1177/1753466619892492.
Copyright (c) 2021 Journal of Rare Diseases and Orphan Drugs
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.